Aspargo Labs has appointed Andrew Chamlin, a veteran of the life sciences industry, to the role of Chief Marketing Officer. Chamlin will lead the development and implementation of commercial strategies for Aspargo's oral spray suspension platform and innovative delivery device. His appointment aims to drive Aspargo Labs’ aggressive global expansion and advancement of their technology pipeline and drug applications.
Who to call at Aspargo Laboratories, and when
A new leader at Aspargo Laboratories brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Aspargo Laboratories raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Aspargo Laboratories, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Aspargo Laboratories. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Aspargo Laboratories
Location
Englewood Cliffs, New Jersey, United States
About
Aspargo Labs, Inc. is a specialty pharmaceutical and MedTech company focused on converting the world’s most meaningful medications into liquid oral suspensions delivered via a proprietary, digitally connected device. Aspargo Labs’ suspension technology offers several key advantages, including improved absorption, ease of administration, flexible dosing, and improved patient adherence. Aspargo is leveraging its unique technology platform to transform a wide range of medications across various therapeutic areas. Aspargo’s initial focus is a liquid oral suspension formulation of sildenafil for the treatment of ED, which the Company markets in Europe and the United Kingdom.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Aspargo Laboratories changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Englewood CliffsBiotechnologyHealthcare